Vivos Inc 2018 Highlights
09 janv. 2019 07h00 HE
|
Vivos Inc.
Richland WA, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) The Board of Directors Reports:In spite of being handcuffed by legacy debt financing, Vivos Inc made considerable...
Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet®
04 déc. 2018 15h50 HE
|
Vivos Inc.
Richland, WA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc. Successfully Administers IsoPet® to a Second Dog for Canine Sarcoma at the University of Missouri
26 oct. 2018 07h00 HE
|
Vivos Inc.
Richland WA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc reported that the second dog in a five-dog series was successfully treated yesterday with Y-90 IsoPet® at the...
Vivos Inc. Reports Strong Reception to IsoPet® At Veterinary Cancer Society Conference
22 oct. 2018 07h00 HE
|
Vivos Inc.
Richland WA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to report that its attendance and presentation at the annual meeting of the Veterinary Cancer Society...
Vivos, Inc. Completes Common Stock Equity Financing to Fund Roll Out of IsoPet™ and Eliminate Toxic Debt
10 oct. 2018 07h00 HE
|
Vivos Inc.
Richland WA, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos, Inc. a pharmaceutical company researching and developing minimally invasive treatments to combat cancer in humans...
Vivos Inc Signs Memorandum of Understanding with Private Veterinary Hospital as Pilot Clinic for Commercial IsoPet® Therapy
02 oct. 2018 07h00 HE
|
Vivos Inc.
Richland, WA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) selected its first clinic for commercial sales of IsoPet Vivos Inc., a pharmaceutical company in the process of researching and...
First Successful Treatment of Canine Sarcoma using IsoPet® to be Presented at Veterinary Cancer Society Conference
26 sept. 2018 07h00 HE
|
Vivos Inc.
Richland, WA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC PINK: RDGL) first therapy to canine treat soft tissue sarcoma is successful Vivos Inc, a pharmaceutical company in the process of...
Amending and Replacing the Initial Press Release on George Sharp; Disregard the first release:
25 sept. 2018 14h15 HE
|
Vivos Inc.
Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc Retains Well-Known Analyst, George Sharp, as Advisor - Updated
25 sept. 2018 11h12 HE
|
Vivos Inc.
Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc Signs a Standstill Agreement with Debt Holders Designed to Halt the Toxic Selling and Eliminate the Secured Toxic Debt
24 sept. 2018 07h00 HE
|
Vivos Inc.
Richland WA , Sept. 24, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to announce that all the debtholders of Vivos’ secured convertible debt have agreed to a ten...